首站-论文投稿智能助手
典型文献
Resveratrol and its derivates improve infl ammatory bowel disease by targeting gut microbiota and infl ammatory signaling pathways
文献摘要:
Inflammatory bowel disease (IBD) is a chronic inflammatory lesion of the intestine, mainly manifested by infiltration of intestinal inflammatory cells and imbalance of gut microbiota. Conventional treatments for IBD include antibiotics, immunosuppressive agents, 5-aminosalicylic acid, steroids and surgery, which have high toxic side effects. Resveratrol is a natural polyphenol, and its various derivatives have anti-oxidation and anti-inflammatory properties. In this paper, we comprehensively review the mechanism of resveratrol and its derivates to alleviate IBD by improving intestinal barrier, regulating the unbalanced gut microbiota, and targeting various inflammatory signaling pathways.
文献关键词:
作者姓名:
Ming Li;Ping Li;Rongxue Tang;Hui Lu
作者机构:
State Key Laboratory of Food Science and Technology,Nanchang University,Nanchang 330047,China
引用格式:
[1]Ming Li;Ping Li;Rongxue Tang;Hui Lu-.Resveratrol and its derivates improve infl ammatory bowel disease by targeting gut microbiota and infl ammatory signaling pathways)[J].食品科学与人类健康(英文),2022(01):22-31
A类:
infl,ammatory
B类:
Resveratrol,its,derivates,improve,bowel,disease,by,targeting,gut,microbiota,signaling,pathways,Inflammatory,IBD,chronic,inflammatory,lesion,intestine,mainly,manifested,infiltration,intestinal,cells,imbalance,Conventional,treatments,include,antibiotics,immunosuppressive,agents,aminosalicylic,acid,steroids,surgery,which,have,high,toxic,side,effects,natural,polyphenol,various,derivatives,oxidation,properties,this,paper,comprehensively,review,mechanism,resveratrol,alleviate,improving,barrier,regulating,unbalanced
AB值:
0.581922
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity
Liu Zuojing;Zhu Shiwei;He Meibo;Li Mo;Wei Hui;Zhang Lu;Sun Qinghua;Jia Qiong;Hu Nan;Fang Yuan;Song Lijin;Zhou Chen;Tao Heqing;Y Kao John;Zhu Huaiqiu;Owyang Chung;Duan Liping-Department of Gastroenterology, Peking University Third Hospital, Haidian District, Beijing 100191, China;Department of Ultrasound, Peking University Third Hospital, Haidian District, Beijing 100191, China;Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China;Department of Biomedical Engineering, College of Engineering, Peking University, Beijing 100187, China;Division of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, 6520 MSRB I, SPC 5682, 1150 West Medical Center Drive, Ann Arbor, MI 48109, USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。